Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2013

01-12-2013 | Original Article

Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays

Authors: Nahoko Yata, Osamu Uemura, Masataka Honda, Takeshi Matsuyama, Kenji Ishikura, Hiroshi Hataya, Takuhito Nagai, Yohei Ikezumi, Naoya Fujita, Shuichi Ito, Kazumoto Iijima, Mari Saito, Tetsuji Keneko, Teruo Kitagawa

Published in: Clinical and Experimental Nephrology | Issue 6/2013

Login to get access

Abstract

Objective

The data available on reference ranges for cystatin C in children are limited, and there are discrepancies among the available data. The aim of this study was to describe the reference ranges for cystatin C in Japanese children by using 4 automated assays.

Methods

Serum cystatin C levels were measured in 1128 Japanese children aged 3 month to 16 years without kidney disease. We calculated age-, gender-, race- and assay-specific cystatin C ranges.

Results

For all 4 assays, the median serum cystatin C levels were raised in term infants compared with older children and decreased by the first 2 years. The median serum cystatin C levels remained constant throughout up to the age of 14 years and decreased in children aged 15–16 years. The median serum cystatin C levels in children aged 12–16 years were slightly higher in males than in females. Assay-specific differences were also observed in the levels of serum cystatin C measured.

Conclusion

Age-, gender-, race- and assay-specific ranges for serum cystatin C should be used as another tool to assess kidney function in children.
Literature
1.
go back to reference Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–8.PubMedCrossRef Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–8.PubMedCrossRef
2.
go back to reference Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38:1933–53.PubMed Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38:1933–53.PubMed
3.
go back to reference Morris MC, Allanby CW, Toseland P, Haycock GB, Chantler C. Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child. 1982;57:611–5.PubMedCrossRefPubMedCentral Morris MC, Allanby CW, Toseland P, Haycock GB, Chantler C. Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child. 1982;57:611–5.PubMedCrossRefPubMedCentral
4.
go back to reference Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571–90.PubMed Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571–90.PubMed
5.
go back to reference Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Yata N, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Kitagawa T. Age, gender, and body length effects on reference serum creatinine level determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol. 2011;15:694–9.PubMedCrossRef Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Yata N, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Kitagawa T. Age, gender, and body length effects on reference serum creatinine level determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol. 2011;15:694–9.PubMedCrossRef
6.
go back to reference Uemura O, Ushijima K, Nagai T, Yamada T, Hayakawa H, Shinkai Y, Kuwabara M. Reference serum creatinine levels determined by an enzymatic method in Japanese children: relationship to body length. Clin Exp Nephrol. 2009;13:585–8.PubMedCrossRef Uemura O, Ushijima K, Nagai T, Yamada T, Hayakawa H, Shinkai Y, Kuwabara M. Reference serum creatinine levels determined by an enzymatic method in Japanese children: relationship to body length. Clin Exp Nephrol. 2009;13:585–8.PubMedCrossRef
7.
go back to reference Grubb A, Lofberg H. Human γ-trace. Structure, function and clinical use of concentration measurements. Scand J Clin Lab Investig. 1985;45:7–13. Grubb A, Lofberg H. Human γ-trace. Structure, function and clinical use of concentration measurements. Scand J Clin Lab Investig. 1985;45:7–13.
8.
go back to reference Olafsson I. The human cystatin C gene promoter: functional analysis and identification of heterogeneous mRNA. Scand J Clin Lab Investig. 1995;55:597–607.CrossRef Olafsson I. The human cystatin C gene promoter: functional analysis and identification of heterogeneous mRNA. Scand J Clin Lab Investig. 1995;55:597–607.CrossRef
9.
go back to reference Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1999;238:20–7. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1999;238:20–7.
10.
go back to reference Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996;56:409–14.PubMedCrossRef Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996;56:409–14.PubMedCrossRef
11.
go back to reference Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol. 1998;12:125–9.PubMedCrossRef Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol. 1998;12:125–9.PubMedCrossRef
12.
go back to reference Finney H, Newman D, Thakkar H, Fell JM, Price CP. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child. 2000;82:71–5.PubMedCrossRefPubMedCentral Finney H, Newman D, Thakkar H, Fell JM, Price CP. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child. 2000;82:71–5.PubMedCrossRefPubMedCentral
13.
go back to reference Li J, Dunn W, Breaud A, Elliott D, Sokoll LJ, Clarke W. Analytical performance of 4 automated assays for measurement of cystatin C. Clin Chem. 2010;56:1336–9.PubMedCrossRef Li J, Dunn W, Breaud A, Elliott D, Sokoll LJ, Clarke W. Analytical performance of 4 automated assays for measurement of cystatin C. Clin Chem. 2010;56:1336–9.PubMedCrossRef
14.
go back to reference Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C—a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101:875–81.PubMedCrossRef Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C—a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101:875–81.PubMedCrossRef
15.
go back to reference Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol. 1998;49:221–5.PubMed Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol. 1998;49:221–5.PubMed
16.
go back to reference Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75:652–60.PubMedCrossRef Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75:652–60.PubMedCrossRef
17.
go back to reference Filler G, Witt I, Priem F, Priem F, Errich JH, Jung K. Are cystatin C and β2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem. 1997;43:1077–8.PubMed Filler G, Witt I, Priem F, Priem F, Errich JH, Jung K. Are cystatin C and β2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem. 1997;43:1077–8.PubMed
18.
go back to reference Uemura O, Ushijima K, Nagai T, Yamada T, Hayakawa H, Nabeta Y, Shinkai Y, Koike K, Kuwabara M. Reference serum cystatin C level in Japanese children. Clin Exp Nephrol. 2010;14:453–6.PubMedCrossRef Uemura O, Ushijima K, Nagai T, Yamada T, Hayakawa H, Nabeta Y, Shinkai Y, Koike K, Kuwabara M. Reference serum cystatin C level in Japanese children. Clin Exp Nephrol. 2010;14:453–6.PubMedCrossRef
19.
go back to reference Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Prinatol. 1999;16:287–95.CrossRef Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Prinatol. 1999;16:287–95.CrossRef
20.
go back to reference Randers E, Krue S, Erlandsen E, Danielsen H, Hansen LG. Reference interval for serum cystatin C in children. Clin Chem. 1999;45:1856–8.PubMed Randers E, Krue S, Erlandsen E, Danielsen H, Hansen LG. Reference interval for serum cystatin C in children. Clin Chem. 1999;45:1856–8.PubMed
21.
go back to reference Groesbeck D, Köttgen A, Parekh R, Selvin E, Schwartz GJ, Coresh J, Furth S. Age, gender, and race effects on cystatin C levels in US adolescents. Clin J Am Nephrol. 2008;3:1777–85.CrossRef Groesbeck D, Köttgen A, Parekh R, Selvin E, Schwartz GJ, Coresh J, Furth S. Age, gender, and race effects on cystatin C levels in US adolescents. Clin J Am Nephrol. 2008;3:1777–85.CrossRef
22.
go back to reference Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48:1619–21.PubMed Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48:1619–21.PubMed
Metadata
Title
Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays
Authors
Nahoko Yata
Osamu Uemura
Masataka Honda
Takeshi Matsuyama
Kenji Ishikura
Hiroshi Hataya
Takuhito Nagai
Yohei Ikezumi
Naoya Fujita
Shuichi Ito
Kazumoto Iijima
Mari Saito
Tetsuji Keneko
Teruo Kitagawa
Publication date
01-12-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0784-x

Other articles of this Issue 6/2013

Clinical and Experimental Nephrology 6/2013 Go to the issue

Acknowledgment

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.